Cell Therapy Manufacturing
Expertise
Expertise
Our years of expertise with lentiviral vector and retroviral vector production, deep understanding of the target cell therapy, long-standing industry experience, and history of academic-industrial partnerships have allowed us to establish close partnerships with experienced cell therapy manufacturers operating directly at the point of care.
Cell Types
- CAR T, NK, T lymphocytes, and other immune cells
- Hematopoietic progenitors and stem cells, including MSCs
- Embryonic and induced pluripotent stem cells (iPSCs)
Services
Services
From bench to clinic, our cell therapy cGMP facilities and manufacturing partners specialize in small-batch production. Alongside our partners, we provide comprehensive and flexible support tailored to your project’s needs. These collaborations allow us to tap into a vast pool of knowledge, experience, and cutting-edge technologies, enabling us to advance your therapies to the clinical stage efficiently. By leveraging these alliances, we help you navigate the complexities of the manufacturing process and accelerate the progression of your therapies from concept to reality within your project timeline.
Unique Cell Therapy Services
- Enrichment or depletion of specific cell subsets
- Genetic modification (transduction)
- Expansion and differentiation
- Cryopreservation
- Cellular stability studies
Partnerships
Leverage our network of dedicated and experienced partners who can support your development and cGMP manufacturing facilitated and simplified by a Genezen project lead.
- GMP aseptic cell transduction procedures
- Certified ISO Class 7 production suites with ISO Class 8 support areas
- Patient testing
- RCL Replication Competent Lentivirus (RCL) PCR-based testing
- Biologic Replication Competent Virus
- RCL
- Replication Competent Retrovirus (RCR)
- PCR Testing
- VSV-G, GALV, and RD114 envelopes
- Adenoviral E1a and SV40 virus T antigen
- VCN
- Insertion Site Analysis
- LAM PCR analysis
Explore Genezen
Explore Genezen
With unique expertise in cGMP lentiviral, retroviral, and AAV vector manufacturing, paired with a new state-of-the-art facility, we have the capacity and know-how to support your viral vector manufacturing needs.
Clinical trial patient sample testing and cell line release testing are readily available to minimize your gene or cell therapy’s time to clinic.